William B. White, MD, on late-breaking trials at ASH 2014
Click Here to Manage Email Alerts
NEW YORK — In this video, William B. White, MD, professor of medicine at Calhoun Cardiology Center, University of Connecticut School of Medicine in Farmington and immediate past president of the American Society of Hypertension, discusses two late-breaking clinical trials presented at the ASH Annual Scientific Meeting.
One trial, presented by researchers at Kaiser Permanente North California, reported BP control rates within their program over the previous 11 years, and indicated a near-doubling of control with the introduction of combination therapy with ACE inhibitors and diuretics. White noted that by 2012, control rates of as high as 80% had been achieved in some locations within the program. He said that this relatively simple approach yielded remarkable results, sufficient to surpass the national average for BP control within the plan.
In a separate presentation, researchers conducted a community-based project with the goal of improving hypertension control throughout upstate New York by instituting a variety of strategies. The use of simple therapies to bring patients' hypertension back under control, he said, also yielded impressive increases to control rates within the area of study, also surpassing the national control average.
White concluded that these two studies, which used different approaches and methods of analysis, both provide evidence of an ability to improve hypertension control — and overall public health — throughout the US.